Cytovance Biologics Capacity Update October 2024: Large Molecule Drug Substance

Conveniently based in the heart of the United States, Cytovance brings decades of expertise in biologics development and cGMP manufacturing to both large pharmaceutical companies and biotech innovators. With a commitment to delivering end-to-end solutions, Cytovance offers extensive capabilities in microbial and mammalian production to support diverse project needs.

Join Rose Rhomberg, Senior Business Development Director, as she presents an in-depth look at Cytovance’s capabilities and highlights the available capacity designed to accelerate your development and manufacturing goals.